Evidence map›Paper›PMID 41097094›Full record

ReviewInternational journal of molecular sciences2025

Methods for Assessing MAGL Enzymatic Activity: An Extensive Review of Past and Emerging Approaches.

Giulia Bononi, Eva Landucci, Miriana Di Stefano, Lisa Piazza, Simone Bertini, Marco Macchia, Carlotta Granchi

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. The biological functions of monoacylglycerol lipase (MAGL) in cancer.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Giulia BononiDepartment of Pharmacy, University of Pisa, Via Bonanno, 6, 56126 Pisa, Italy.ORCID 0000-0002-4336-4344
Eva LanducciDepartment of Pharmacy, University of Pisa, Via Bonanno, 6, 56126 Pisa, Italy.ORCID 0009-0001-5017-3925
Miriana Di StefanoDepartment of Pharmacy, University of Pisa, Via Bonanno, 6, 56126 Pisa, Italy.ORCID 0000-0001-6727-5816
Lisa PiazzaDepartment of Pharmacy, University of Pisa, Via Bonanno, 6, 56126 Pisa, Italy.ORCID 0009-0007-5062-4590
Simone BertiniDepartment of Pharmacy, University of Pisa, Via Bonanno, 6, 56126 Pisa, Italy.ORCID 0000-0001-8832-8075
Marco MacchiaDepartment of Pharmacy, University of Pisa, Via Bonanno, 6, 56126 Pisa, Italy.
Carlotta GranchiDepartment of Pharmacy, University of Pisa, Via Bonanno, 6, 56126 Pisa, Italy.ORCID 0000-0002-5849-0722

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Monoacylglycerol lipase (MAGL) is a key serine hydrolase involved in lipid metabolism, catalyzing the hydrolysis of monoacylglycerols into free fatty acids and glycerol. MAGL plays a central role in regulating endocannabinoid signaling and lipid homeostasis, processes often dysregulated in cancer and other pathological conditions. In recent years, MAGL has emerged as a promising therapeutic target, particularly in oncology, where its inhibition has shown potential to impair tumor growth, metastasis, and inflammation-driven processes. Alongside the development of selective MAGL inhibitors, several biochemical methods have been established to measure MAGL enzymatic activity, providing essential tools for target validation and inhibitor characterization. In this review, we provide a comprehensive and critical overview of the main approaches developed for MAGL activity evaluation, including radiometric, chromatographic, colorimetric, fluorescence-based, bioluminescence-based, and activity-based protein profiling (ABPP) assays. For each method, we discuss principles, advantages, and limitations. This review aims to support researchers in the selection of the most appropriate assay strategy for their experimental needs, ultimately fostering the rapid and accurate development of novel MAGL inhibitors with potential applications in cancer therapy and metabolic disease management.

Indexed as

Enzyme AssaysMonoacylglycerol LipasesAnimalsEnzyme InhibitorsHumansLipid MetabolismNeoplasmsEnzyme InhibitorsMonoacylglycerol Lipasesbiochemical methodsenzymatic activityenzymatic assaysMAGLmonoacylglycerol lipase

Identifiers

PMID41097094
PMCPMC12525366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.